Transcriptomics

Dataset Information

0

The cardiac glycoside deslanoside imposes an anticancer effect on prostate cancer involving multiple signaling pathways


ABSTRACT: Prostate cancer (PCa) is a leading cause of cancer-related deaths among men worldwide, and advanced prostate cancers are mostly incurable. It is urgently needed to find new therapeutic options. Deslanoside is a cardiac glycoside, the efficacy of which on cancers has never been reported. In this study, we investigated the effects of deslanoside on advanced PCa for the first time. RNA-sequencing results identified 141 differentially expressed mRNAs in deslanoside-treated PCa cells compared to untreated cells, which were significantly enriched in the cancer-associated pathways, including necroptosis, MAPK signaling pathway, NOD-like receptor signaling pathway, focal adhesion, small lung cancer, GnRH signaling pathway, IL-17 signaling pathway, TNF signaling pathway and apoptosis. Kaplan-Meier plotter analysis identified the effects of 11 deslanoside-influenced genes on recurrence-free survival and 4 genes on overall survival. Taken together, these results repurpose that a novel utilization of deslanoside in prostate cancer, which exerts profound inhibitory effects on advanced PCa progression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE184380 | GEO | 2021/12/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-09-23 | GSE150368 | GEO
2020-03-04 | PXD013422 | Pride
2022-12-31 | GSE215335 | GEO
2021-07-01 | E-MTAB-10704 | biostudies-arrayexpress
2023-06-21 | PXD022005 | Pride
2013-10-07 | E-GEOD-48403 | biostudies-arrayexpress
2024-06-14 | GSE227108 | GEO
2024-06-14 | GSE227107 | GEO
2014-09-18 | E-GEOD-51005 | biostudies-arrayexpress
| PRJNA764252 | ENA